TABLE I.
Demographic, clinical, tumour, and treatment characteristics
| Characteristic |
Value
|
|
|---|---|---|
| (n) | (%) | |
| Patients | 83 | 100 |
| Age (years) | ||
| Median | 62 | |
| Range | 37–79 | |
| Sex | ||
| Men | 66 | 79.5 |
| Women | 17 | 20.5 |
| Cancer site | ||
| Distal esophagus | 26 | 31.3 |
| Gastroesophageal junction | 32 | 38.6 |
| Stomach | 25 | 30.1 |
| Histology | ||
| Adenocarcinoma | 83 | 100 |
| Signet-ring appearance | 22 | 26.5 |
| Symptoms | ||
| Dysphagia | 51 | 61.4 |
| Weight loss | 45 | 54.2 |
| Epigastric pain or discomfort | 20 | 24.0 |
| Gastrointestinal bleeding | 9 | 10.8 |
| Nausea | 8 | 9.6 |
| Smoking | ||
| Yes | 52 | 62.7 |
| No | 31 | 37.3 |
| Comorbidities | ||
| Yes | 61 | 73.5 |
| No | 22 | 26.5 |
| Type of chemotherapy | ||
| Epirubicin–cisplatin–5-fluorouracil | 23 | 27.7 |
| Epirubicin–cisplatin–capecitabine | 60 | 72.3 |
| Chemotherapy cycles | ||
| Preoperative | ||
| 1 | 5 | 6.0 |
| 2 | 5 | 6.0 |
| 3 | 73 | 88.0 |
| Postoperative | ||
| 0 | 35 | 42.2 |
| 1 | 5 | 6.0 |
| 2 | 6 | 7.2 |
| 3 | 37 | 44.6 |
| Surgery | ||
| Yes | 78 | 94.0 |
| No | 5 | 6.0 |
| R0 resection | ||
| Yes | 59 | 71 |
| No | 24 | 29 |